Stakeholder perspectives on the regulation of homeopathy in Germany: a qualitative interview study and normative analysis
Year: 2026
Type: article
Abstract: BACKGROUND: Although homeopathy continues to be the one of the most popular types of alternative medicine in Germany, its regulation is increasingly being debated. In recent years, prominent players have spoken out in favour of removing the option of reimbursement by statutory health insurance companies while its continued reimbursed is strongly advocated by proponents. This study aims to explore key stakeholders' views about the current regulation of homeopathy in Germany. METHODS: Semi-structured qualitative individual interviews were conducted between March and October 2023 with 28 participants from different groups, including statutory health insurance companies, German medical and pharmaceutical associations, State Medical Councils, homeopathic practitioners, and outspoken homeopathy critics. The transcripts were analysed using conventional content analysis. RESULTS: The current liberal regulation of homeopathy in Germany was seen as problematic by most participants. Representatives of health insurance companies shared that their companies' incentives to reimburse homeopathy are mainly due to strategic reasons (competitive advantage), while they remain sceptical of the actual effectiveness of homeopathy. Furthermore, there was a pragmatic acceptance of the use of homeopathy by health care professionals despite confidence in its effectiveness being low. There was a growing consensus towards the need to tighten the regulation of homeopathy in Germany. CONCLUSION: We argue that the current regulation of homeopathy in Germany is ethically inappropriate. Homeopathy should not be treated differently by law, but should instead be held to the same standards as other therapies. The special legal regulations regarding homeopathy should be removed to create uniformity and equality.
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,195
Funder: Technische Universität München
OpenAlex ID: W7234479941
